August 17, 2017 / 7:20 PM / 2 years ago

Plaintiff in Xarelto trial hits back at Bayer's motion for judgment

A Mississippi woman who said she developed severe internal bleeding after taking Bayer AG and Johnson & Johnson’s blood thinner Xarelto asked a federal court on Thursday to dismiss a motion by the drugmakers for judgment as a matter of law.

The case in the U.S. District Court for the Southern District of Mississippi is the third to go to trial out of more than 18,600 similar lawsuits in federal and state courts alleging Xarelto makers provided inadequate warnings about the bleeding risk from the drug.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below